THE USE OF TRASTUZUMAB IN METASTATIC BREAST CANCER PATIENTS BEYOND DISEASE PROGRESSION

被引：0
|
作者：
Papadopoulos, P. [1 ]
Brunetto, A. [1 ]
Ashley, S. [1 ]
Allen, M. [1 ]
Johnston, S. [1 ]
Smith, I. [1 ]
O'Brien, M. [1 ]
机构：
[1] Royal Marsden Hosp, Drug Dev Unit, Sutton, Surrey, England
来源：
ANNALS OF ONCOLOGY | 2008年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：65 / 66
页数：2
相关论文
共 50 条
  • [1] Trastuzumab beyond progression in metastatic breast cancer
    Yanmaz, Mustafa T.
    Ozguroglu, Mustafa
    Ozturk, Betul
    Uygun, Kazim
    Basaran, Gul
    Turna, Hande
    Yildiz, Ozcan
    Baran, Ahmet
    Demir, Gokhan
    Buyukunal, Evin
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : 77 - 77
  • [2] Continuing trastuzumab beyond disease progression: outcomes analysis in patients with metastatic breast cancer
    Cancello, Giuseppe
    Montagna, Emilia
    D'Agostino, Diego
    Giuliano, Mario
    Giordano, Antonio
    Di Lorenzo, Giuseppe
    Plaitano, Monica
    De Placido, Sabino
    De Laurentiis, Michele
    [J]. BREAST CANCER RESEARCH, 2008, 10 (04):
  • [3] Continuing trastuzumab beyond disease progression: outcomes analysis in patients with metastatic breast cancer
    Giuseppe Cancello
    Emilia Montagna
    Diego D'Agostino
    Mario Giuliano
    Antonio Giordano
    Giuseppe Di Lorenzo
    Monica Plaitano
    Sabino De Placido
    Michele De Laurentiis
    [J]. Breast Cancer Research, 10
  • [4] Safety of treatment of metastatic breast cancer with trastuzumab beyond disease progression
    Tripathy, D
    Slamon, DJ
    Cobleigh, M
    Arnold, A
    Saleh, M
    Mortimer, JE
    Murphy, M
    Stewart, SJ
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (06) : 1063 - 1070
  • [5] Trastuzumab and lapatinib beyond trastuzumab progression for metastatic breast cancer: strategies and pitfalls
    Brandes, Alba A.
    Franceschi, Enrico
    Tosoni, Alicia
    Degli Esposti, Roberta
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2010, 10 (02) : 179 - 184
  • [6] Trastuzumab-containing therapies activity beyond disease progression in metastatic breast cancer
    Garcia-Saenz, Jose Angel
    Martin, Miguel
    Puente, Javier
    Lopez-Tarruella, Sara
    Casado, Antonio
    Moreno, Fernando
    Grande, Enrique
    Diaz-Rubio, Eduardo
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 39 - 40
  • [7] Trastuzumab use beyond progression on previous trastuzumab treatment in HER-2 positive metastatic breast cancer
    Hutka, Margaret M.
    Kolosza, Zofia
    Utracka-Hutka, Beata
    [J]. ANNALS OF ONCOLOGY, 2007, 18 : 163 - 163
  • [8] TRASTUZUMAB BEYOND PROGRESSION IN PATIENTS WITH HER-2/NEU POSITIVE METASTATIC BREAST CANCER
    Eralp, Yesim
    [J]. JOURNAL OF BREAST HEALTH, 2009, 5 (01): : 3 - 8
  • [9] Termination of trastuzumab in HER2-positive metastatic breast cancer patients who received trastuzumab beyond progression
    Izzet Dogan
    Esra Aydin
    Nijat Khanmammadov
    Nail Paksoy
    Pinar Saip
    Adnan Aydiner
    [J]. Scientific Reports, 13
  • [10] Termination of trastuzumab in HER2-positive metastatic breast cancer patients who received trastuzumab beyond progression
    Dogan, Izzet
    Aydin, Esra
    Khanmammadov, Nijat
    Paksoy, Nail
    Saip, Pinar
    Aydiner, Adnan
    [J]. SCIENTIFIC REPORTS, 2023, 13 (01)
12345